SouthState Bank Corp Has $22.09 Million Stake in Intuitive Surgical, Inc. $ISRG

SouthState Bank Corp lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.6% during the 1st quarter, HoldingsChannel.com reports. The firm owned 47,907 shares of the medical equipment provider’s stock after buying an additional 2,557 shares during the quarter. Intuitive Surgical accounts for about 1.0% of SouthState Bank Corp’s holdings, making the stock its 24th biggest position. SouthState Bank Corp’s holdings in Intuitive Surgical were worth $22,085,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC increased its position in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the period. Sivia Capital Partners LLC raised its holdings in shares of Intuitive Surgical by 3.8% during the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after purchasing an additional 34 shares during the period. Schnieders Capital Management LLC. raised its stake in Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after buying an additional 268 shares during the period. Osterweis Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the second quarter worth approximately $200,000. Finally, Main Street Financial Solutions LLC lifted its stake in shares of Intuitive Surgical by 92.4% in the second quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock valued at $1,592,000 after buying an additional 1,407 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts and market watchers still point to solid underlying business momentum, including strong da Vinci procedure growth, continued da Vinci 5 adoption, and expectations that Intuitive Surgical could beat Q2 earnings estimates. Article Title
• Positive Sentiment: Some commentary says the recent weakness reflects investor sentiment and valuation concerns more than company fundamentals, suggesting the long-term growth story remains intact. Article Title
• Neutral Sentiment: The company is heading into its July 16 earnings report, which is keeping traders on the sidelines and increasing volatility ahead of the release. Article Title
• Negative Sentiment: Fresh analyst price-target cuts, including TD Cowen’s reduction to $520 from $585, have reinforced concerns about valuation, competition, international-market challenges, and tariff pressure on margins. Article Title
• Negative Sentiment: The stock also saw unusually heavy put buying and a broader pullback in medtech names, signaling that some investors are positioning defensively ahead of earnings. Article Title

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on ISRG shares. BTIG Research set a $512.00 target price on Intuitive Surgical in a report on Monday. Leerink Partners reduced their target price on shares of Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a research report on Wednesday, April 22nd. Jefferies Financial Group lowered their price objective on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research note on Wednesday, April 22nd. JPMorgan Chase & Co. dropped their target price on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Finally, Barclays set a $651.00 price objective on shares of Intuitive Surgical and gave the company an “overweight” rating in a research report on Thursday, April 23rd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $566.27.

Insiders Place Their Bets

In related news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the sale, the executive vice president owned 5,720 shares of the company’s stock, valued at $2,426,080.80. The trade was a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 7,169 shares of company stock worth $3,059,135. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $379.50 on Wednesday. The business’s 50 day simple moving average is $419.65 and its two-hundred day simple moving average is $471.31. Intuitive Surgical, Inc. has a one year low of $378.50 and a one year high of $603.88. The stock has a market capitalization of $134.40 billion, a P/E ratio of 46.00, a price-to-earnings-growth ratio of 3.31 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s revenue was up 23.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.81 EPS. Sell-side analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.